Nivolumab Hypersensitivity Reactions a Myth or Reality in Solid Tumors—A Systematic Review of the Literature

Immune-checkpoint inhibitors (ICIs) are the most effective treatments nowadays. Nivolumab was the second ICI used for treating solid tumors with amazing results. Patients treated with Nivolumab may react differently to this treatment. Some people tolerate this treatment very well without experiencin...

Descripción completa

Detalles Bibliográficos
Autores principales: Pîrlog, Cristina-Florina, Paroșanu, Andreea Ioana, Slavu, Cristina Orlov, Olaru, Mihaela, Popa, Ana Maria, Iaciu, Cristian, Niță, Irina, Moțatu, Pompilia, Horia, Cotan, Manolescu, Loredana Sabina Cornelia, Nițipir, Cornelia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9777769/
https://www.ncbi.nlm.nih.gov/pubmed/36547155
http://dx.doi.org/10.3390/curroncol29120741

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9777769/
https://www.ncbi.nlm.nih.gov/pubmed/36547155
http://dx.doi.org/10.3390/curroncol29120741

Ejemplares similares